1. 120TiP Conversion of response to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: A randomized phase Ib/IIa trial. (December 2022) Authors: Borgers, J.S.W.; Burgers, F.; Terveer, E.M.; van Leerdam, M.; Korse, T.M.; Kessels, R.; Henderickx, J.G.E.; Flohil, C.C.; van Dijk, M.; Keller, J.J.; Verspaget, H.W.; Kuijper, E.J.; Haanen, J.B.A.G. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗